Feasibility of a preventive HIV-1 vaccine cohort among persons attending sexually transmitted disease clinics in Thailand

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 5, 1999, Pages 488-494

  Markowitz, Lauri E ^a,b,f,h   Sirisopana, Narongrid ^a   Charonwatanachokchai, Angkana ^c   Julvanichpong, Wichai ^d   Siraprapasiri, Taweesap ^e   Palanuvej, Thanit ^c   Siriwongrangsun, Patchara ^c   Tungsakul, Vilaiwan ^a   Pumratana, Kanya ^a   Chitwarakorn, Anupong ^c   Michael, Rodney A ^a,g   Brown, Arthur E ^a  

^a ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Venereal Disease Control Division   (Thailand)

^d Venereal Dis and AIDS Contr Ctr 3   (Thailand)

^e Provincial Health Office   (Thailand)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g Mil Infect Dis Research Program   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Asia; HIV 1 incidence; Sexually transmitted diseases; Thailand; Vaccine

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; THAILAND; VACCINATION; VIRUS INFECTION; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033561034     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199904150-00012     Document Type: Article

References (25)

1. Esparza J, Osmanov S, Kallings L, Wigzell H. Planning for HIV vaccine trials: the World Health Organization perspective. AIDS 1991;5:S159-63.
2. Phanuphak P, Teeratakulpixarn S, Sarangbin S, et al. International clinical trials of HIV vaccines: 1. Phase I trial of an HIV-1 synthetic peptide vaccine in Bangkok, Thailand. Asian Pac J Allergy Immunol 1997;15:41-8.
3. Brown A, McNeil J. HIV vaccine development: a subtype E-specific strategy. Southeast Asian J Trop Med Public Health 1998;29:377-82.
4. Pitisuttithum P, Migasena S, Laothai A, Suntharasamai P, Kumpong C, Vanichseni S. Drug behaviours and comprehension among intravenous drug users volunteered for HIV vaccine trial. J Med Assoc Thai 1997;80:47-50.
5. Heyward WL, Osmanov S, Saba J, et al. Preparation of phase III HIV vaccine efficacy trials: methods for the determination of HIV incidence. AIDS 1994;8:1285-91.
6. Weniger B. Experience from HIV incidence cohorts in Thailand: implications for HIV vaccine efficacy trials. AIDS 1994;8:1007-10.
7. Nelson KE, Beyrer C, Natpratan C, Eiumtrakul S, Celentano D, Khamboonruang C. Preparatory studies for possible HIV vaccine trials in Northern Thailand. AIDS Res Hum Retroviruses 1994;10: S243-46.
8. Kitayaporn D, Vanichseni S, Mastro TD, et al. Characteristics of injecting drug users (IDUs) infected with HIV-1 subtypes B and E in a prospective cohort in Bangkok [abstract], 4th International Congress on AIDS in Asia and the Pacific, Manila, the Philippines, 1997.
9. Natpratan C, Nantakwang D, Beyrer C, et al. Feasibility of northern Thai factory workers as participants in HIV vaccine trials. SE Asian J Trop Med Public Health 1996;27:457-62.
10. Renzullo PO, Celentano DD, Beyrer C, et al. HIV infection and risk behaviors in Thai men after their service in the Royal Thai Army: informing vaccine cohort development. AIDS Behav (in press).
11. Kaplan HA, Sempos CT. Statistical Methods in Epidemiology. New York: Oxford University Press 1989:206-25.
12. Rojanapithayakorn W, Hanenberg R. The 100% condom program in Thailand. AIDS 1996;10:1-7.
13. Nelson NE, Celentano, DD, Eiumtrakol S, et al. Changes in sexual behavior and a decline in HIV infection among young men in Thailand. N Engl J Med 1996;335:297-303.
14. Celentano DD, Nelson KE, Lyles CM, et al. Declining incidence of HIV and sexually transmitted diseases in young Thai men: evidence for success of the HIV/AIDS control and prevention program. AIDS 1998;12:F29-36.
15. Rida W, Fast P, Hoff R, Fleming T. Intermediate-size trials for the evaluation of HIV vaccine candidates: a workshop summary. J Acquir Defic Syndr Hum Retrovirol 1997;16:195-203.
16. Mills S, Benjarattanaporn P, Bennett A, et al. HIV risk behavioral surveillance in Bangkok, Thailand: sexual behavior trends among eight population groups. AIDS 1997;11:S43-51.
17. Cegielski JP, Beyrer C, Natpratan C, et al. HIV and syphilis incidence in men attending sexually transmitted disease (STD)/ anonymous HIV testing and counseling clinics in Northern Thailand, 1996-1997. XII International Conference on AIDS, Geneva, Switzerland, 1998
18. Koblin BA, Taylor PE, Avrett S, Stevens CE. The feasibility of HIV-1 vaccine efficacy trials among gay/bisexual men in New York City: Project ACHIEVE. AIDS 1996;10:1555-61.
19. Buchbinder SP, Douglas JM, McKirnan DJ, Judson FN, Katz MH, MacQueen KM. Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence and willingness to participate. J Infect Dis 1996; 174:954-61.
20. Jackson D, Rakwar JP, Richardson BA, et al. Decreased incidence of sexually transmitted diseases among trucking company workers in Kenya: results of a behavioral risk-reduction programme. AIDS 1997;11:903-9.
21. Ng'weshemi JZL, Boerma JT, Pool R, et al. Changes in male sexual behavior in response to the AIDS epidemic: evidence from a cohort study in urban Tanzania. AIDS 1996;10:1415-20.
22. Hanenberg RS, Rojanapithayakorn W, Kunasol P, Sokal DC. Impact of Thailand's HIV control programme as indicated by the decline of sexually transmitted diseases. Lancet 1994;344:243-5.
23. Mehendale SM, Rodrigues JJ, Brookmeyer RS, et al. Incidence and predictors of human immunodeficiency virus type I seroconversion in patients attending sexually transmitted disease clinics in India. J Infect Dis 1995;172;1486-91.
24. Otten M, Zaidi A, Peterman T, et al. High rate of HIV serocon-version among patients attending urban sexually transmitted disease clinics. AIDS 1994;8:549-53.
25. Figueroa JP, Ward E, Morris J, et al. Incidence of HIV and HTLV-1 infection among sexually transmitted disease clinic attenders in Jamaica. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:232-7.